| One year in review 2018: pathogenesis of rheumatoid arthritis |
42 |
| One year in review 2019: pathogenesis of rheumatoid arthritis |
36 |
| One year in review 2019: Sjogren's syndrome |
29 |
| Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial |
25 |
| Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus |
22 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 500 patients (Sjogren Big Data Project) |
21 |
| One year in review 2018: Behcet's syndrome |
20 |
| The function of microRNAs in cartilage and osteoarthritis |
20 |
| One year in review 2019: systemic sclerosis |
19 |
| One year in review 2019: Behcet's syndrome |
15 |
| Osteoarthritis is a serious disease |
15 |
| Danger signals and inflammaging in osteoarthritis |
15 |
| One year in review 2017: spondyloarthritis |
15 |
| One year in review 2019: vasculitis |
15 |
| Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients |
14 |
| Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature |
14 |
| Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs |
14 |
| Imaging in primary Sjogren's syndrome: the obsolete and the new |
14 |
| One year in review 2019: systemic lupus erythematosus |
14 |
| Innate inflammation and synovial macrophages in osteoarthritis pathophysiology |
14 |
| Comprehensive evaluation of finger flexor tendon entheseal soft tissue and bone changes by ultrasound can differentiate psoriatic arthritis and rheumatoid arthritis |
13 |
| Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study |
13 |
| Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy |
13 |
| One year in review 2018: systemic vasculitis |
13 |
| Timing of onset affects arthritis presentation pattern in antisynthetase syndrome |
12 |
| Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR) |
12 |
| One year in review 2019: novelties in the treatment of rheumatoid arthritis |
12 |
| Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition |
12 |
| The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib |
12 |
| One year in review 2018: systemic lupus erythematosus |
12 |
| Bcl-XL and Mcl-1 upregulation by calreticulin promotes apoptosis resistance of fibroblast-like synoviocytes via activation of PI3K/Akt and STAT3 pathways in rheumatoid arthritis |
11 |
| Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups |
11 |
| Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease |
11 |
| Severe, life-threatening phenotype of primary Sjogren's syndrome: clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry) |
11 |
| Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjogren's syndrome |
11 |
| Physical therapy for patients with knee and hip osteoarthritis: supervised, active treatment is current best practice |
10 |
| Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis |
10 |
| The different clinical patterns of giant cell arteritis |
10 |
| Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitis |
10 |
| One year in review 2018: psoriatic arthritis |
10 |
| Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects |
10 |
| Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement |
10 |
| Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis |
10 |
| Association between primary Sjogren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis |
9 |
| The role of salivary gland histopathology in primary Sjogren's syndrome: promises and pitfalls |
9 |
| Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis |
9 |
| One year in review 2018: gout |
9 |
| A probability score to aid the diagnosis of suspected giant cell arteritis |
9 |
| The kaleidoscope of neurological manifestations in primary Sjogren's syndrome |
9 |
| The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever |
9 |
